Abstract
Objectives
To explore the views and perspectives of children on the unlicensed/off-label use of medicines in children and on the participation of children in clinical trials.
Methods
Focus-group discussions, involving school children, were carried out in a range of primary and secondary schools in Northern Ireland. A purposeful sample was chosen to facilitate representation of various socioeconomic groupings.
Results
A total of 123 pupils, aged from 10 to 16 years, from six schools, participated in 16 focus groups. In general, pupils viewed the unlicensed/off-label use of medicines in children as unsafe and unethical and felt it is necessary to test medicines in children to improve the availability of licensed products. The majority felt that older children should be told, and that parents should be told, about the unlicensed/off-label use of medicines in children, yet they recognised some implications of this, such as potential medication non-adherence.
Conclusions
This is the first study to explore the views of healthy children on unlicensed medicine use in children. Children were able to recognise potential risks associated with the unlicensed use of medicines and felt it is necessary to test and license more medicines in children.
Practice implications
Health care professionals should consider the views of children in decisions that affect their health.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Reference
Shah SS, Hall M, Goodman DM et al (2007) Off-label drug use in hospitalized children. Arch Pediatr Adolesc Med 161:282–290
Stewart D, Rouf A, Snaith A et al (2007) Attitudes and experiences of community pharmacists towards paediatric off-label prescribing: a prospective survey. Br J Clin Pharmacol 64:90–95
Lindell-Osuagwu L, Korhonen MJ, Saano S et al (2009) Off-label and unlicensed drug prescribing in three paediatric wards in Finland and review of the international literature. J Clin Pharm Ther 34:277–287
Pandolfini C, Bonati M (2005) A literature review on off-label drug use in children. Eur J Pediatr 164:552–558
Horen B, Montastruc JL, Lapeyre-Mestre M (2002) Adverse drug reactions and off-label drug use in paediatric outpatients. Br J Clin Pharmacol 54:665–670
Ufer M, Kimland E, Bergman U (2004) Adverse drug reactions and off-label prescribing for paediatric outpatients: a one-year survey of spontaneous reports in Sweden. Pharmacoepidemiol Drug Saf 13:147–152
Turner S, Nunn AJ, Fielding K, Choonara I (1999) Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study. Acta Paediatr 88:965–968
Neubert A, Dormann H, Weiss J et al (2004) The impact of unlicensed and off-label drug use on adverse drug reactions in paediatric patients. Drug Saf 27:1059–1067
Sammons H (2009) Ethical issues of clinical trials in children: a European perspective. Arch Dis Child 94:474–477
EEC (2006) Regulation (EC) No 1901 / 2006 of the European Parliament and of the Council of 12 December 2006 on medicinal products for paediatric use and amending Regulation (EEC) No 1768 / 92, Directive 2001 / 20 / EC, Directive 2001 / 83 / EC and Regulation (EC) No 726 / 2004. Off J Eur Union 378:1–19
Chappuy H, Doz F, Blanche S et al (2008) Children's views on their involvement in clinical research. Pediatr Blood Cancer 50:1043–1046
Chappuy H, Doz F, Blanche S et al (2006) Parental consent in paediatric clinical research. Arch Dis Child 91:112–116
Braun V, Clarke V (2006) Using thematic analysis in psycology. Qual Res Psychol 3:77–101
Pope C, Ziebland S, Mays N (2000) Qualitative research in health care. Analysing qualitative data. BMJ 320:114–116
Barbour RS (2001) Checklists for improving rigour in qualitative research: a case of the tail wagging the dog? BMJ 322:1115–1117
Morgan M, Gibbs S, Maxwell K et al (2002) Hearing children’s voices: methodological issues in conducting focus groups with children aged 7–11 years. Qual Res 2:5–20
Bush PJ, Davidson FR (1982) Medicines and "drugs": what do children think? Health Educ Q 9:209–2024
Menacker F, Aramburuzabala P, Minian N et al (1999) Children and medicines: what they want to know and how they want to learn. J Soc Adm Pharm 16:38–52
Darbyshire P, MacDougall C, Schiller W (2005) Multiple methods in qualitative research with children: more insight or just more? Qual Res 5:417–436
Trakas DJ (ed) (2009) Focus groups revisited: lessons from qualitative research with children. LIT, Berlin
Almarsdottir AB, Zimmer C (1998) Children’s knowledge about medicines. Child Glob J Child Res 5:265–281
Bush PJ, Iannotti RJ, Davidson FR (1982) A longitudinal study of children and medicines. In: Breimer DD, Speiser P (eds) Topics in pharmaceutical sciences. Elsevier, New York
Trakas DJ, Sanz E (eds) (1992) Studying childhood and medicine use, a multidisciplinary approach. ZHTA Medical, Athens
Trakas D, Sanz E (eds) (1996) Childhood and medicine use in a cross-cultural perspective: a European concerted action. Report EUR 16646 EN. European Commission, Brussels
De Maria C, Lussie MT, Bajcar J (2011) What do children know about medications? A review of the literature to guide clinical practice. Can Fam Physician 57:291–295
Cherrill J, Hudson H, Cocking C et al (2010) Clinical trials: the viewpoint of children with a chronic illness compared to healthy children. Arch Dis Child 19:229–232
Tait AR, Voepel-Lewis T, Malviya S (2003) Do they understand? (part II): assent of children participating in clinical anesthesia and surgery research. Anesthesiology 98:609–614
Ondrusek N, Abramovitch R, Pencharz P, Koren G (1998) Empirical examination of the ability of children to consent to clinical research. J Med Ethics 24:158–165
Mukattash TL, Millership JS, Collier PS, McElnay JC (2008) Public awareness and views on unlicensed use of medicines in children. Br J Clin Pharmacol 66:838–845
Young FE (1989) It's time to talk about children's medications. Questa 23:44–46
Zachry WM, Ginsburg DB (2001) Patient autonomy and the regulation of direct-to-consumer advertising. Clin Ther 23:2024–2037
Cherrill J, Hudson H, Cocking C et al (2007) Clinical trials: the viewpoint of children. Arch Dis Child 92:712–713
Wendler D, Jenkins T (2008) Children's and their parents' views on facing research risks for the benefit of others. Arch Pediatr Adolesc Med 162:9–14
Wolthers OD (2006) A questionnaire on factors influencing children's assent and dissent to nontherapeutic research. J Med Ethics 32: 292–297
Balen R, Blyth E, Calabretto H, Fraser C, Horrocks C, Manby M (2006) Involving children in health and social research: ‘human becomings’ or ‘active beings’? Childhood 13:29–48
Garcia M, Sanz E, Aramburuzabala P et al (1996) Concepts of adverse drug reactions among children in eight countries. In: Bush PJ, Trakas DJ, Sanz E (eds) Children, medicines, and culture. Pharmaceutical Products Press, New York
Britten N, Ukoumunne OC, Boulton MG (2002) Patients’ attitudes to medicines and expectations for prescriptions. Health Expect 5:256–269
Townsend A, Hunt K, Wyke S (2003) Managing multiple morbidity in mid-life: a qualitative study of attitudes to drug use. BMJ 327:837–841
John T, Hope T, Savulescu J et al (2008) Children's consent and paediatric research: is it appropriate for healthy children to be the decision-makers in clinical research? Arch Dis Child 93:379–383
Weithorn LA, Campbell SB (1982) The competency of children and adolescents to make informed treatment decisions. Child Dev 53:1589–1598
Acknowledgment
We gratefully thank all children who took part in the focus-group discussions and all teachers who facilitated the research.
Competing interests
None declared.
Author information
Authors and Affiliations
Corresponding author
Additional information
An abstract on this research work was presented at the British Pharmaceutical Conference, 2008.
Appendix 1
Appendix 1
All slides simply contained a title and pictures (Table 3). The researcher, using terminology appropriate to age, explained the process of drug discovery, animal testing and testing in man before medicinal products are licensed and released on to the market. He then explained that some medicines are not tested and licensed for use in children and raised the question of dosage selection for medicines which were not licensed.
Rights and permissions
About this article
Cite this article
Mukattash, T., Trew, K., Hawwa, A.F. et al. Children’s views on unlicensed/off-label paediatric prescribing and paediatric clinical trials. Eur J Clin Pharmacol 68, 141–148 (2012). https://doi.org/10.1007/s00228-011-1110-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-011-1110-8